Jefferies Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Jefferies Group’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,000	Closed	-$20K	–	2939
2019 Q4	$20K	Hold	5,000	–	–	﹤0.01%	2477
2019 Q3	$25K	Sell	5,000 -83,800	-94%	-$469K	﹤0.01%	2622
2019 Q2	$541K	Buy	+88,800	New	+$472K	﹤0.01%	1631
2019 Q1	–	Sell	-28,500	Closed	-$384K	–	2801
2018 Q4	$384K	Sell	28,500 -20,000	-41%	-$337K	﹤0.01%	1568
2018 Q3	$941K	Buy	48,500 +28,500	+143%	+$607K	0.01%	1356
2018 Q2	$511K	Buy	20,000 +2,000	+11%	+$46.6K	﹤0.01%	1581
2018 Q1	$363K	Hold	18,000	–	–	﹤0.01%	1693
2017 Q4	$361K	Buy	+18,000	New	+$354K	﹤0.01%	1919

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Jefferies Group's DPLO Position: Q1 2020 in Review

Jefferies Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 11,008 shares — an estimated $44K sold.

Jefferies Group first reported a position in DPLO in Q2 2015 and held it in 8 quarters. The position peaked at $736K in Q3 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Jefferies Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 11,008 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $44K.
Jefferies Group first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 8 quarters.
Jefferies Group's DIPLOMAT PHARMACY, INC. position peaked at $736K in Q3 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.